Temozolomide for recurrent low-grade spinal cord gliomas in adults.

@article{Chamberlain2008TemozolomideFR,
  title={Temozolomide for recurrent low-grade spinal cord gliomas in adults.},
  author={Marc C Chamberlain},
  journal={Cancer},
  year={2008},
  volume={113 5},
  pages={1019-24}
}
BACKGROUND There is no standard therapy for surgery- and radiotherapy-resistant, recurrent, low-grade spinal cord gliomas. Therefore, a retrospective study of temozolomide (TMZ) in adults with recurrent low-grade spinal cord gliomas with a primary objective of determining progression-free survival (PFS) was performed. METHODS Twenty-two patients (11 men and 11 women) aged 20 years to 55 years (median, 35 years) with recurrent spinal cord gliomas (World Health Organization grade 2 astrocytoma… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…